Vestibular Neurectomy Effective for Severe Meniere Disease
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 6, 2024 -- Vestibular neurectomy is an effective vertigo treatment in patients with severe Meniere disease, according to a study published online June 7 in the Journal of Clinical Medicine.
Agnieszka Jasińska-Nowacka, M.D., Ph.D., from the Medical University of Warsaw in Poland, and colleagues evaluated functional outcomes and balance compensation in patients with severe Meniere disease after vestibular neurectomy. The analysis included data from 20 patients with unilateral Meniere disease before and two years after vestibular neurectomy.
The researchers found that all patients reported a complete resolution of vertigo attacks after the vestibular neurectomy, while 95 percent of patients reported functional-level improvement according to a scale proposed by the American Academy of Otolaryngology-Head and Neck Surgery. All patients showed clinical improvement in the Dizziness Handicap Inventory, with the average result decreasing from 81.7 to 16.4. There were no statistically significant differences between the sensory organization test results before and after vestibular neurectomy. There were significant correlations between a patient’s age and postoperative results of the Dizziness Handicap Inventory and posturography.
"Vestibular neurectomy is an effective vertigo treatment in patients with severe Meniere disease with no clinical improvement despite conservative treatment," the authors write. "It results in subjective physical, functional, and emotional improvement, enabling patients to return to daily activities and work."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma
FRIDAY, July 18, 2025 -- Neoadjuvant systemic treatment (NST) followed by adjuvant treatment with nivolumab and relatlimab offers long-term benefit in adults with stage III/IV...
Diagnostic Model Based on Delayed Post-Gadolinium Enhancement MRI Accurate for Meniere Disease
TUESDAY, July 15, 2025 -- A diagnostic model based on delayed post-gadolinium enhancement magnetic resonance imaging (DEMRI) improves the accuracy of Meniere disease (MD)...
Velar Adhesion Reduces Cleft Width Prior to Palatoplasty in Cleft Lip
TUESDAY, July 15, 2025 -- For patients with unilateral cleft lip and palate (UCLP), velar adhesion (VA) reduces cleft width prior to palatoplasty and is associated with a lower...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.